Background: For millions of people worldwide with kidney failure, a well-functioning vascular access, like an arteriovenous fistula (AVF), is essential for life-sustaining hemodialysis. However, the standard method requires puncturing the same AVF with two needles three times a week, which over time can damage the vessel, leading to scarring, narrowing, and frequent failures. These complications often require repeated surgical or minimally invasive procedures (reinterventions), causing significant pain, high medical costs, and exhaustion of the patient's limited blood vessels. New Approach: This study will evaluate a modified puncture technique called the Single-Needle Distal Return (SNDR) strategy for long-term AVF care. Instead of using two needles in the AVF, only one needle is placed in the AVF to draw blood. The cleaned blood is then returned to the body through a second needle placed in a superficial vein in the foot or lower leg. This approach aims to reduce trauma to the critical AVF. Study Plan: This is a clinical study conducted at the Blood Purification Center of Anhui Medical University Affiliated Suzhou Hospital. We plan to enroll approximately 50 adult hemodialysis patients who use an AVF and are willing to try the SNDR technique. For comparison, we will also observe data from a similar number of patients receiving standard two-needle AVF care during the same period. The study will last about three years. We will closely monitor patients using the SNDR technique to assess: Effectiveness: Whether dialysis remains adequate (measured by Kt/V). Safety: Rates of complications (like bruising or infection), dialysis machine alarms, and venous pressure during treatment. Practical Benefits: Whether it reduces the need for repair procedures (reinterventions) and hospitalizations related to the AVF. Economic Impact: Changes in healthcare costs. Patient Experience: Patient tolerance and comfort with the technique. We will also analyze the characteristics of patients who successfully use this technique long-term to help identify who might benefit most from it in the future. Potential Significance: If proven successful and safe for long-term use, the SNDR strategy could help protect a patient's precious AVF, potentially reducing painful procedures, lowering costs, slowing down the exhaustion of blood vessels, and improving the quality of life for people on long-term dialysis. The findings may also guide better planning for vascular access care.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
100
For each hemodialysis session, only a single needle is used to cannulate the arteriovenous fistula (AVF) to establish arterial blood inflow. The venous return is established by cannulating a superficial vein in the distal lower extremity (such as the dorsal foot vein or a tributary of the great saphenous vein), which is separate from the AVF. This approach aims to minimize repetitive trauma to the AVF segment itself.
For each hemodialysis session, the established standard of care is followed. This involves cannulating the arteriovenous fistula (AVF) with two separate needles: one placed proximally (or in the arterial segment) to establish blood inflow, and a second placed distally (or in the venous segment) to return dialyzed blood. This is the conventional method for maintenance hemodialysis via an AVF.
Suzhou Hospital Affiliated to Anhui Medical University
Suzhou, Anhui, China
RECRUITINGChange in dialysis adequacy (single-pool Kt/V) from baseline to study completion.
Time frame: From enrollment to the end of the 24-month follow-up period.
Annualized rate of access-related reinterventions (e.g., angioplasty, thrombectomy, surgical revision).
Time frame: From enrollment to the end of the 24-month follow-up period.
Total access-related healthcare costs per patient-year.
Time frame: From enrollment to the end of the 24-month follow-up period.
Rate of hospitalizations primarily due to vascular access complications.
Time frame: From enrollment to the end of the 24-month follow-up period.
Incidence of cannulation-related adverse events (e.g., hematoma, infection, severe bleeding).
Time frame: Assessed at each hemodialysis session throughout the study, up to 24 months.
Proportion of hemodialysis sessions with significant machine alarms requiring staff intervention.
Time frame: Assessed at each hemodialysis session throughout the study, up to 24 months.
Patient-reported tolerance and satisfaction assessed via a standardized questionnaire.
Time frame: At 6 months, 12 months, and at study completion (24 months).
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.